We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 March 2021 highlighting future growth drivers of the Division.
We will welcome you to the event in our new virtual 360° platform which will be accessible one day prior to the event (as of 15:00 CET). We would like to invite you to visit our virtual marketplace and participate in a self-guided virtual showroom tour. Stay tuned!
14:00-16:00 CET / 13:00-15:00 GMT
9:00-11:00am EDT / 6:00-8:00am PDT
The event will address the following topics:
Speakers will include:
Thomas Schinecker, CEO Roche Diagnostics
Ann Costello, Global Head Roche Diagnostics Solutions
Palani Kumaresan, Global Head of Research & Development
Benjamin Lilienfeld, Life Cycle Leader Serum Work Area Systems
Michael Hombach, Global Clinical Leader Infectious Diseases
Andre Ziegler, Global Clinical Leader Cardiology
Jill German, Global Head of Pathology Lab
The webinar will start with presentations, followed by a Q&A session (live access to the speakers).
Access to virtual event (pre-registration required):
Please pre-register for our webinar here until 15 March 2021.
A replay of the event will be available via > ir.roche.com
*privacy notice
Best regards, | |
Karl Mahler |
Birgit Masjost Investor Relations Officer |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
get the latest news and updates to your inbox.